Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer-Cachexia (NSCLC-C): An Extension Study
Phase of Trial: Phase III
Latest Information Update: 14 Jul 2017
Price : $35 *
At a glance
- Drugs Anamorelin (Primary)
- Indications Anorexia; Cachexia
- Focus Adverse reactions; Registrational
- Acronyms ROMANA-3
- Sponsors Helsinn Therapeutics
- 02 Sep 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
- 24 Jul 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.